Abbvie Inc (ABBV US)

187

Analysis

Health Care • United States

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Refresh

Exchange Announcement • 06 Oct 2026 04:07

Current Report (Form 8-K | Period ending 2026-10-05)

Exchange Announcement • 03 Sep 2026 20:47

Current Report (Form 8-K | Period ending 2026-09-03)

Exchange Announcement • 07 Aug 2026 05:08

424B5 | Prospectus

Exchange Announcement • 06 Aug 2026 05:17

Current Report (Form 8-K | Period ending 2026-08-04)

Exchange Announcement • 04 Aug 2026 20:18

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00